SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-000625 to Adagio Medical Holdings, Inc. (ADGM) (CIK 0002006986) (ADGM)

Adagio Medical Holdings, Inc. (ADGM) (CIK 0002006986)
Date: Jan. 22, 2025 · CIK: 0002006986 · Accession: 0000000000-25-000625

AI Filing Summary & Sentiment

File numbers found in text: 333-284266

Date
January 22, 2025
Author
Not clearly detected
Form
UPLOAD
Company
Adagio Medical Holdings, Inc. (ADGM) (CIK 0002006986)

Letter

January 22, 2025 Todd Usen Chief Executive Officer Adagio Medical Holdings, Inc. 26051 Merit Circle, Suite 102 Laguna Hills, CA 92653 Re:Adagio Medical Holdings, Inc. Registration Statement on Form S-1 Filed January 14, 2025 File No. 333-284266 Dear Todd Usen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Michael Lee, Esq.

Show Raw Text
January 22, 2025
Todd Usen
Chief Executive Officer
Adagio Medical Holdings, Inc.
26051 Merit Circle, Suite 102
Laguna Hills, CA 92653
Re:Adagio Medical Holdings, Inc.
Registration Statement on Form S-1
Filed January 14, 2025
File No. 333-284266
Dear Todd Usen:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Michael Lee, Esq.